Bacteriophages targeting adherent invasive Escherichia coli strains as a promising new treatment for Crohn's disease

Journal of Crohn's and Colitis

Volumn 11, Issue 7, 2017, Pages 840-847

  Galtier, Matthieu ^a,b   De Sordi, Luisa ^a   Sivignon, Adeline ^c   de Vallée, Amélie ^c   Maura, Damien ^a,b,d   Neut, Christel ^e,f   Rahmouni, Oumaira ^e,f   Wannerberger, Kristin ^g   Darfeuille Michaud, Arlette ^c   Desreumaux, Pierre ^f,h   Barnich, Nicolas ^c   Debarbieux, Laurent ^a  

^a INSTITUT PASTEUR   (France)

^b UNIVERSITÉ PARIS DESCARTES   (France)

^c UNIVERSITÉ CLERMONT AUVERGNE   (France)

^d MASSACHUSETTS GENERAL HOSPITAL   (United States)

^e UNIV LILLE   (France)

^f UNIVERSITÉ DE LILLE   (France)

^g Ferring Pharmaceuticals AS   (Denmark)

^h LILLE UNIVERSITY HOSPITAL   (France)

Author keywords

Antibiotics; Colitis; Dysbiosis; Microbiota; Phage therapy

Indexed keywords

CARCINOEMBRYONIC ANTIGEN RELATED CELL ADHESION MOLECULE 6; PROBIOTIC AGENT; CEACAM6 PROTEIN, HUMAN; CELL ADHESION MOLECULE; GLYCOSYLPHOSPHATIDYLINOSITOL ANCHORED PROTEIN; LEUKOCYTE ANTIGEN;

ADHERENT INVASIVE ESCHERICHIA COLI LF82; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BACTERIAL COLONIZATION; BACTERIAL STRAIN; BACTERIOPHAGE; COLITIS; CONTROLLED STUDY; CROHN DISEASE; ESCHERICHIA COLI; EX VIVO STUDY; FECES ANALYSIS; FEMALE; HUMAN; HUMAN TISSUE; ILEUM; IN VIVO STUDY; INTESTINE BIOPSY; INTESTINE MUCOSA; MOUSE; NONHUMAN; PRIORITY JOURNAL; SYMPTOM; TRANSGENIC MOUSE; VIRUS REPLICATION; VIRUS VIRULENCE; ANIMAL; CECUM; CHEMICALLY INDUCED; COLON; CYTOLOGY; EPITHELIUM CELL; FECES; GROWTH, DEVELOPMENT AND AGING; METABOLISM; MICROBIOLOGY; PHAGE THERAPY; VIROLOGY;

ANIMALS; ANTIGENS, CD; BACTERIOPHAGES; CECUM; CELL ADHESION MOLECULES; COLITIS; COLON; CROHN DISEASE; EPITHELIAL CELLS; ESCHERICHIA COLI; FECES; FEMALE; GPI-LINKED PROTEINS; HUMANS; ILEUM; INTESTINAL MUCOSA; MICE; MICE, TRANSGENIC; PHAGE THERAPY;

EID: 85028673472     PISSN: 18739946     EISSN: 18764479     Source Type: Journal    
DOI: 10.1093/ecco-jcc/jjw224     Document Type: Article

References (49)

1. Xavier RJ, Podolsky DK. Unravelling the pathogenesis of inflammatory bowel disease. Nature 2007;448:427-34.
2. Liu JZ, van Sommeren S, Huang H, et al.; International Multiple Sclerosis Genetics Consortium; International IBD Genetics Consortium. Association analyses identify 38 susceptibility loci for inflammatory bowel disease and highlight shared genetic risk across populations. Nat Genet 2015;47:979-86.
3. Legaki E, Gazouli M. Influence of environmental factors in the development of inflammatory bowel diseases. World J Gastrointest Pharmacol Ther 2016;7:112-25.
4. Carbonnel F, Jantchou P, Monnet E, Cosnes J. Environmental risk factors in Crohn's disease and ulcerative colitis: an update. Gastroenterol Clin Biol 2009;33[Suppl 3]:S145-57.
5. Frank DN, St Amand AL, Feldman RA, Boedeker EC, Harpaz N, Pace NR. Molecular-phylogenetic characterization of microbial community imbalances in human inflammatory bowel diseases. Proc Natl Acad Sci U S A 2007;104:13780-5.
6. Kaur N, Chen CC, Luther J, Kao JY. Intestinal dysbiosis in inflammatory bowel disease. Gut Microbes 2011;2:211-6.
7. Miquel S, Peyretaillade E, Claret L, et al. Complete genome sequence of Crohn's disease-associated adherent-invasive E. Coli strain lf82. PLoS One 2010;5:e12714.
8. Darfeuille-Michaud A, Neut C, Barnich N, et al. Presence of adherent Escherichia coli strains in ileal mucosa of patients with Crohn's disease. Gastroenterology 1998;115:1405-13.
9. Barnich N, Carvalho FA, Glasser AL, et al. CEACAM6 acts as a receptor for adherent-invasive E. coli, supporting ileal mucosa colonisation in Crohn disease. J Clin Invest 2007;117:1566-74.
10. Carvalho FA, Barnich N, Sivignon A, et al. Crohn's disease adherent-invasive Escherichia coli colonise and induce strong gut inflammation in transgenic mice expressing human CEACAM. J Exp Med 2009;206:2179-89.
11. Hansen JJ, Sartor RB. Therapeutic manipulation of the microbiome in IBD: current results and future approaches. Curr Treat Options Gastroenterol 2015;13:105-20.
12. World Health Organization. Antimicrobial Resistance: Global Report on Surveillance 2014. http://www.who.int/drugresistance/documents/surveillancereport/en/. Accessed December 20, 2016.
13. Nicolas-Chanoine MH, Bertrand X, Madec JY. Escherichia coli ST131, an intriguing clonal group. Clin Microbiol Rev 2014;27:543-74.
14. Liu YY, Wang Y, Walsh TR, et al. Emergence of plasmid-mediated colistin resistance mechanism MCR-1 in animals and human beings in China: a microbiological and molecular biological study. Lancet Infect Dis 2016;16:161-8.
15. Lübbert C, Straube L, Stein C, et al. Colonisation with extended-spectrum beta-lactamase-producing and carbapenemase-producing Enterobacteriaceae in international travelers returning to Germany. Int J Med Microbiol 2015;305:148-56.
16. Bernasconi OJ, Kuenzli E, Pires J, et al. Travelers can import colistin-resistant enterobacteriaceae, including those possessing the plasmid-mediated MCR-1 gene. Antimicrob Agents Chemother 2016;60:5080-4.
17. Broaders E, Gahan CG, Marchesi JR. Mobile genetic elements of the human gastrointestinal tract: potential for spread of antibiotic resistance genes. Gut Microbes 2013;4:271-80.
18. Sulakvelidze A, Alavidze Z, Morris JG Jr. Bacteriophage therapy. Antimicrob Agents Chemother 2001;45:649-59.
19. Abedon ST, Kuhl SJ, Blasdel BG, Kutter EM. Phage treatment of human infections. Bacteriophage 2011;1:66-85.
20. Knoll BM, Mylonakis E. Antibacterial bioagents based on principles of bacteriophage biology: an overview. Clin Infect Dis 2014;58:528-34.
21. Reyes A, Haynes M, Hanson N, et al. Viruses in the faecal microbiota of monozygotic twins and their mothers. Nature 2010;466:334-8.
22. Hoyles L, McCartney AL, Neve H, et al. Characterization of virus-like particles associated with the human faecal and caecal microbiota. Res Microbiol 2014;165:803-12.
23. McCallin S, Alam Sarker S, Barretto C, et al. Safety analysis of a Russian phage cocktail: from metagenomic analysis to oral application in healthy human subjects. Virology 2013;443:187-96.
24. Sarker SA, Sultana S, Reuteler G, et al. Oral phage therapy of acute bacterial diarrhea with two coliphage preparations: a randomized trial in children from Bangladesh. EBioMed 2016;4:124-37.
25. Galtier M, De Sordi L, Maura D, et al. Bacteriophages to reduce gut carriage of antibiotic resistant uropathogens with low impact on microbiota composition. Environ Microbiol 2016;18:2237-45.
26. Chan CH, Stanners CP. Novel mouse model for carcinoembryonic antigen-based therapy. Mol Ther 2004;9:775-85.
27. Datsenko KA, Wanner BL. One-step inactivation of chromosomal genes in Escherichia coli K-12 using PCR products. Proc Natl Acad Sci U S A 2000;97:6640-5.
28. Chaveroche MK, Ghigo JM, d'Enfert C. A rapid method for efficient gene replacement in the filamentous fungus Aspergillus nidulans. Nucleic Acids Res 2000;28:E97.
29. Debarbieux L, Leduc D, Maura D, et al. Bacteriophages can treat and prevent Pseudomonas aeruginosa lung infections. J Infect Dis 2010;201:1096-104.
30. Ochman H, Selander RK. Standard reference strains of Escherichia coli from natural populations. J Bacteriol 1984;157:690-3.
31. Maura D, Galtier M, Le Bouguénec C, Debarbieux L. Virulent bacteriophages can target O104:H4 enteroaggregative Escherichia coli in the mouse intestine. Antimicrob Agents Chemother 2012;56:6235-42.
32. Furet JP, Firmesse O, Gourmelon M, et al. Comparative assessment of human and farm animal faecal microbiota using real-time quantitative PCR. FEMS Microbiol Ecol 2009;68:351-62.
33. Bouguen G, Langlois A, Djouina M, et al. Intestinal steroidogenesis controls PPARγ expression in the colon and is impaired during ulcerative colitis. Gut 2015;64:901-10.
34. Gevers D, Kugathasan S, Denson LA, et al. The treatment-naive microbiome in new-onset Crohn's disease. Cell Host Microbe 2014;15:382-92.
35. Sarker SA, Sultana S, Reuteler G, et al. Oral phage therapy of acute bacterial diarrhea with two coliphage preparations: a randomized trial in children from Bangladesh. EBioMed 2016;4:124-37.
36. Dufour N, Clermont O, La Combe B, et al.; ColoColi group. Bacteriophage LM33_P1, a fast-acting weapon against the pandemic ST131-O25b:H4 Escherichia coli clonal complex. J Antimicrob Chemother 2016;71:3072-80.
37. Jakobsson HE, Rodríguez-Piñeiro AM, Schütte A, et al. The composition of the gut microbiota shapes the colon mucus barrier. EMBO Rep 2015;16:164-77.
38. Johansson ME, Sjövall H, Hansson GC. The gastrointestinal mucus system in health and disease. Nat Rev Gastroenterol Hepatol 2013;10:352-61.
39. Nielsen AT, Dolganov NA, Rasmussen T, et al. A bistable switch and anatomical site control Vibrio cholerae virulence gene expression in the intestine. PLoS Pathog 2010;6:e1001102.
40. Li H, Limenitakis JP, Fuhrer T, et al. The outer mucus layer hosts a distinct intestinal microbial niche. Nat Commun 2015;6:8292.
41. Barr JJ, Auro R, Furlan M, et al. Bacteriophage adhering to mucus provide a non-host-derived immunity. Proc Natl Acad Sci U S A 2013;110:10771-6.
42. Barr JJ, Auro R, Sam-Soon N, et al. Subdiffusive motion of bacteriophage in mucosal surfaces increases the frequency of bacterial encounters. Proc Natl Acad Sci U S A 2015;112:13675-80.
43. Weiss M, Denou E, Bruttin A, Serra-Moreno R, Dillmann ML, Brüssow H. In vivo replication of T4 and T7 bacteriophages in germ-free mice colonised with Escherichia coli. Virology 2009;393:16-23.
44. Chibani-Chennoufi S, Sidoti J, Bruttin A, Kutter E, Sarker S, Brüssow H. In vitro and in vivo bacteriolytic activities of Escherichia coli phages: implications for phage therapy. Antimicrob Agents Chemother 2004;48:2558-69.
45. Sarker SA, McCallin S, Barretto C, et al. Oral T4-like phage cocktail application to healthy adult volunteers from Bangladesh. Virology 2012;434:222-32.
46. Lim ES, Zhou Y, Zhao G, et al. Early life dynamics of the human gut virome and bacterial microbiome in infants. Nat Med 2015;21:1228-34.
47. Debarbieux L. Bacterial sensing of bacteriophages in communities: the search for the Rosetta stone. Curr Opin Microbiol 2014;20:125-30.
48. Norman JM, Handley SA, Baldridge MT, et al. Disease-specific alterations in the enteric virome in inflammatory bowel disease. Cell 2015;160:447-60.
49. De Paepe M, Leclerc M, Tinsley CR, Petit MA. Bacteriophages: an underestimated role in human and animal health? Front Cell Infect Microbiol 2014;4:39.